2 completed, 1 recruiting. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Central Auditory Disease: new trials by email Literature Review of Central Auditory Disease trials Research Report on Central Auditory Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound Clemastine Fumarate Combined With Engineered Sound, Clemastine Fumarate Combined With Pink Noise, Placebo Drug With Engineered Sound - Central Auditory Processing Disorder, Hearing Impaired (Partially) | Phase 1 / Phase 2 | Recruiting | University of Colorado, Denver | 344 | 2025-03-31 | 2026-04-30 |
| taVNS Effect on Central Auditory Processing transcutaneous auricular vagus nerve stimulation (taVNS), Sham device - Central Auditory Disease, Auditory Processing Disorder, Central | Not applicable | Completed | Medipol University | 70 | 2023-04-01 | 2025-05-14 |
| Testing a Possible Cause of Reduced Ability of Children to Process Speech in Noise Central Auditory Disease, Healthy | Completed | National Institute on Deafness and Other Communication Disorders (NIDCD) | 100 | 1999-11-01 | 2008-03-04 |
Auditory Diseases, Central (3) · Language Development Disorders (2) · Auditory Perceptual Disorders (1) · Hearing Disorders (1) · Hearing Loss (1) · Hearing Loss, Hidden (1) · Hearing Loss, Noise-Induced (1) · Hearing Loss, Sensorineural (1) · Presbycusis (1) · Speech Disorders (1)
Brain Diseases (3) · Central Nervous System Diseases (3) · Communication Disorders (3) · Ear Diseases (3) · Language Disorders (3) · Nervous System Diseases (3) · Neurobehavioral Manifestations (3) · Neurologic Manifestations (3) · Otorhinolaryngologic Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Retrocochlear Diseases (3) · Signs and Symptoms (3) · Cognition Disorders (1) · Mental Disorders (1) · Neurocognitive Disorders (1)
Clemastine (1) · Placebo Effect (1)
Medipol University (1) · National Institute on Deafness and Other Communication Disorders (NIDCD) (1) · University of Colorado, Denver (1)
United States (2) · Turkey (Türkiye) (1)
Achim Klug, PhD (1) · Samuel A Budoff, PhD, MS (1)